Literature DB >> 24325159

[Precancerous conditions and lesions of the stomach].

P Falt, M Hanousek, E Kundrátová, O Urban.   

Abstract

Gastric carcinoma is a common malignant disease associated with an unfavorable prognosis in the case of late dia-gnosis. The most significant precancerous condition is chronic atrophic gastritis and intestinal metaplasia caused by Helicobacter pylori infection. These longlasting changes may lead to formation of dysplastic precancerous lesions. Upper endoscopy and histologic examination of forceps bio-psy specimens play a key role in the dia-gnosis of gastric precancerous conditions and lesions. Helicobacter pylori eradication therapy and endoscopic surveillance are main therapeutic modalities of gastric precancerous conditions. Localized precancerous lesions and early gastric neoplasia without the risk of lymphatic spread could be cured by means of endoscopic resection techniques.

Entities:  

Keywords:  gastric cancer -  precancerous conditions -  gastritis -  Helicobacter pylori -  gastroscopy

Mesh:

Year:  2013        PMID: 24325159     DOI: 10.14735/amko2013s22

Source DB:  PubMed          Journal:  Klin Onkol        ISSN: 0862-495X


  3 in total

1.  Effect of Helicobacter pylori on cyclooxygenase-2 and inducible nitric oxide synthase in patients with gastric precancerous lesions and its clinical significance.

Authors:  Hui Zhang; Chunsheng Ding; Zhimin Suo; Yuhua Kang
Journal:  Exp Ther Med       Date:  2015-03-26       Impact factor: 2.447

2.  Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK.

Authors:  Xiaoying Zhou; Guifang Xu; Chengqiang Yin; Wujuan Jin; Guoxin Zhang
Journal:  Oncotarget       Date:  2014-11-30

3.  Characteristics of gastric precancerous conditions and Helicobacter pylori infection among dyspeptic patients in north-eastern Iran: is endoscopic biopsy and histopathological assessment necessary?

Authors:  Abbas Esmaeilzadeh; Ladan Goshayeshi; Robert Bergquist; Lida Jarahi; Alireza Khooei; Alireza Fazeli; Hooman Mosannen Mozaffari; Ali Bahari; Mohammad Bagher Oghazian; Benyamin Hoseini
Journal:  BMC Cancer       Date:  2021-10-26       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.